Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Sermorelin
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Trade names | Geref, Gerel |
Other names | GRF 1–29 |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration |
Injection |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C149H246N44O42S |
Molar mass | 3357.93 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Sermorelin acetate (INN; brand names Geref, Gerel), also known as GHRH (1-29), is a peptide analogue of growth hormone-releasing hormone (GHRH) which is used as a diagnostic agent to assess growth hormone (GH) secretion for the purpose of diagnosing growth hormone deficiency. It is a 29-amino acid polypeptide representing the 1–29 fragment from endogenous human GHRH, thought to be the shortest fully functional fragment of GHRH.
See also
GH (somatotropin) |
|
---|---|
GHIH (somatostatin) |
|
GHRH (somatocrinin) |
|
GHS (ghrelin) |
|
IGF-1 (somatomedin) |
|